Gothenburg, Sweden – Denator AB today announced that it has completed the fifth round of financing, raising a total of 12 million SEK The new shares have been subscribed by existing investors including T-bolaget, Wikow Ventures AB, SGP Group & Servisen Holding AB as well as new private investors. The financing round will strengthen Denator’s […]

AUSTIN, Texas – Luminex Corporation (Nasdaq: LMNX) today announced that the company’s Board of Directors has authorized the purchase of up to 1,000,000 shares, but not more than $21 million in aggregate purchase price, of the company’s common stock through November 2011. “We believe that the stock repurchase program announced today represents an appropriate and […]

BERGISCH GLADBACH, Germany – RI Research Instruments GmbH, a majority-owned subsidiary of Bruker Energy & Supercon Technologies, Inc. (BEST), today announced the award of an approximately 5.5 million Euro (USD $7.4 million) contract from Lund University’s MAX-lab for the supply of 40 radio-frequency (rf) structures and related bunch compressing cavities for the linear accelerator (linac) […]

SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today reported revenues of $1.58 billion for the fourth fiscal quarter ended Oct. 31, 2010, 35 percent above one year ago, or 26 percent excluding the effects of the Varian acquisition and recent divestitures(2). Fourth-quarter GAAP net income was $232 million, or $0.66 per diluted share. […]

Mountain View, Calif. – Complete Genomics, Inc. (NASDAQ: GNOM) announced the pricing of its initial public offering of 6,000,000 shares of its common stock at $9.00 per share. Complete Genomics has granted the underwriters a 30-day option to purchase up to 900,000 additional shares at the initial public offering price, less the underwriting discounts and […]

PLEASANTON, Calif. – IntegenX, Inc. (IXI), a developer of automated DNA and RNA based sample preparation systems, today announced that it has been awarded four grants totaling $976,000 under the Qualifying Therapeutic Discovery Project Program (QTDP). The IntegenX programs focus on developing platforms for DNA sample preparation, next-generation sequencing library preparation, and sample-to-answer analysis of […]

Sunnyvale, CA – SciGene, a developer of instruments that automate the sample processing workflow used for microarray based tests, announced today that it has been awarded a grant in excess of $240,000 under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance development of an automated genetic analysis system for a variety of human diseases. […]

ALAMEDA, Calif. – BioTime, Inc. (NYSE Amex:BTX) today announced that in the last 18 months it has received cumulative total proceeds of $24,174,733 from exercises of warrants that expired November 1, 2010. A remaining 24,976 common share purchase warrants expired unexercised. BioTime now has approximately $32 million of cash on hand on a consolidated basis. […]

SOUTH EASTON, Mass. – Pressure BioSciences, Inc. (Nasdaq:PBIO) (“PBI” and the “Company”) today announced that it has been awarded a Therapeutic Discovery Grant (“TDG”) for $244,479.25. The TDG Program is part of the Patient Protection and Affordable Care Act of 2010 signed into law on March 23, 2010. Grant funds are not taxable for federal […]

Funding Will Allow The Company To Continue Its Efforts On The Licensing And Design Of Planned Uranium De-Conversion And Fluorine Extraction Processing Facility IDAHO FALLS, Idaho – International Isotopes Inc. (OTC Bulletin Board: INIS) announces completion of a private placement on October 29, 2010 that will immediately provide the company with approximately $5.8 million in […]